RecruitingNANCT07588737

Multimodal Artificial Intelligence-Guided Symptom Monitoring and Recovery Management After Lung Cancer Surgery: A 20-Center Prospective Randomized Controlled Trial

Sponsor: The First Affiliated Hospital of Guangzhou Medical University

Trial Details

ConditionPostoperative Care, Rehabilitation, Artificial Intelligence (Al), Randomized Controlled Trial (RCT)
InterventionConventional Internet-Based Rehabilitation Information; Large Language Model-Assisted Rehabilitation Nursing
PhaseNA
StatusRecruiting
Participants868
Est. Completion31 Dec 2026
Last Updated15 May 2026

Primary Outcome

Number of MDASI-LC-Derived Target Symptom Threshold Events Within 30 Days After Surgery

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: 1. Age 18 years or older. 2. Clinically or pathologically diagnosed with lung cancer. 3. Undergoing lung cancer-related thoracic surgery. 4. Surgical procedures may include video-assisted thoracoscopic surgery, robot-assisted thoracic surgery, or open thoracic surgery. 5. Surgical extent may include wedge resection, segmentectomy, lobectomy, sleeve resection, combined resection, bilobectomy, or pneumonectomy. 6. Clinically stable after surgery and able to participate in symptom assessment and postoperative recovery management. 7. Able to use a smartphone or study device, or has a caregiver who can assist with use. 8. Able to complete patient-reported symptom assessments and postoperative recovery information reporting. 9. Provides written informed consent. Exclusion Criteria: 1. Patients receiving non-surgical treatment only. 2. Patients undergoing bronchoscopy, percutaneous biopsy, or other non-surgical diagnostic or therapeutic procedures only. 3. Clinically unstable after surgery and unable to participate in symptom assessment or recovery management. 4. Requiring prolonged intensive care unit treatment, continuous advanced life support, or continuous intensive medical management. 5. Severe cognitive impairment, psychiatric disorder, language communication disorder, or other conditions that preclude completion of study assessments. 6. Unable to use a smartphone or study device and without a caregiver who can assist with use. 7. Currently participating in another interventional clinical study that may affect the primary outcome of this trial. 8. Any other condition judged by the investigator to make the patient unsuitable for participation in this study.

Trial Sites

Countries

China
View Registry Entry

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service